abstract |
This invention concerns compounds and a pharmaceutical composition of the structure wherein: (I) R2 is selected from the group consisting of F and and (II), m is 1, 2 or 3. These compounds are reagents and pharmaceutical compositions have pro-drug and apoptosis properties and are useful in a variety of therapies, for diseases such as arthritis, ALS, MS. |